Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

التفاصيل البيبلوغرافية
العنوان: Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors
المؤلفون: National Cancer Institute (NCI)
المساهمون: Pamela Munster, Principal Investigator
المصدر: A Phase I/Ib Study of Olaparib and ASTX727 in BRCA1/2- and HRD-mutated Tumors
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06177171Test
قاعدة البيانات: ClinicalTrials.gov